Skip to search formSkip to main contentSkip to account menu

NSC-79037

Known as: NSC 79037, NSC79037 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1975
1975
A total of 103 patients with lung cancer was treated with CCNU 130 mg/m2 orally every 6 weeks; 65 patients survived at least 6… 
1975
1975
Twenty-two patients with MOPP-resistant stage IVB Hodgkin's disease were treated with a combination of bleomycin and CCNU. The… 
1973
1973
Summary The binding of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU), labeled with 14 C in the carbonyl moiety, to albumin… 
Highly Cited
1973
Highly Cited
1973
CCNU (1‐[2‐chloroethyl]‐3‐cyclohexyl‐1‐nitrosourea, NSC‐79037), was used to treat 141 evaluable patients with a variety of… 
1972
1972
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea was used at a dosage of 130 mg/sq m administered p.o. in the treatment of 51…